Austar Lifesciences Limited (6118.HK) HKSE
0.75
-0.01(-1.32%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.75
-0.01(-1.32%)
Currency In HKD
| Market Cap | 274.41M |
| Enterprise Value | 509.56M |
| P/E Ratio | 9.62 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 0.23 |
| Price/Book Ratio | 0.42 |
| Enterprise/Revenue | 0.36 |
| Enterprise/EBITDA | 7.35 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | 0.02 |
| Operating Margin | 0.04 |
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
| Revenue | 1.5B |
| Revenue/Share | 2.85 |
| Gross Profit | 301.22M |
| EBITDA | 70.71M |
| Net Income | 16.08M |
| Diluted EPS | 0.03 |
| Total Cash | 165.66M |
| Total Cash/Share | 0.32 |
| Total Debt | 357.16M |
| Total Debt/Equity | 0.44 |
| Current Ratio | 1.37 |
| Book Value Per Share | 1.58 |
| 52-Week Change | -12.79 |
| 52-Week High | 1.97 |
| 52-Week Low | 0.65 |
| Moving Average 50 Days | 0.84 |
| Moving Average 200 Days | 1 |
| Average Volume | 134,238 |
| Shares Outstanding | 512.58M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |